# Hunza Ventures

> Hunza Ventures is a VC fund in Luxembourg backing Medical, Health Care and Biotechnology. See 2 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Luxembourg, Luxembourg
- Total investments: 2
- Last investment: May 2012
- Lead investor: 0%
- Last updated: Aug 2026
- Website: http://www.hunza-ventures.com/index.html

Hunza Ventures is a venture capital firm incorporated in 1998 in Luxemburg. The firm has focused its investments on early and mid-stage life sciences and IT companies with outstanding growth prospects.Hunza Ventures has built a large and well-balanced portfolio based on the strong entrepreneurial experience of the fund’s shareholders andmanagers. Since inception, Hunza Ventures has backed 20 companies in Belgium, Israel, USA and Singapore.Hunza Ventures has raised two funds:Hunza Ventures raised €15 million. The fund made 14 venture investments and is fully invested. A series of companies have successfully been divested.Hunza Ventures II raised €6.25 million in October 2008. This fund is actively investing and is currently raising additional capital.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 2 | 100% |
| Health Care | 2 | 100% |
| Biotechnology | 2 | 100% |
| Pharmaceutical | 1 | 50% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 1 | 50% |
| Funding Round | 1 | 50% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Belgium | 1 | 50% |
| United States | 1 | 50% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| ITeos Therapeutics | ITeos Therapeutics is a private biotechnology company targeting the metabolism of the tumor microenvironment to develop small molecule immunomodulators for cancer treatments. iTeos is building its activities upon the unparalleled expertise of the Ludwig Cancer Research (LICR) – a world-class Research Institute in the fields of tumor immunology,therapeutic cancer vaccines, cancer biology, and translational medicine in cancer.iTeos endeavors to develop small molecules designed to target the tumor microenvironment by inhibiting cancer-induced immune suppression. Targeting such resistance mechanisms will enhance the clinical efficacy of both standards of care treatments as well as the newer immunomodulatory therapies based on the blockade of immune checkpoints (e.g. anti-CTLA4, anti-PD1, and anti-PDL1 antibodies). | $9.9M | Series A | May 03, 2012 |  |
| Formac Pharmaceuticals | Formac is a spin-off company from the University of Leuven, Belgium (K.U.Leuven), from which it has obtained the exclusive and worldwide rights to develop and commercialise ordered mesoporous silica materials for the delivery of poorly soluble API's. The company was incorporated on 3 October 2007 and is privately owned. The main shareholdersof Formac are K.U.Leuven, Allegro Investment Fund, Hunza Ventures, Gemma Frisius Fonds K.U.Leuven, Vinnof PMV and Life Sciences Research Partners VZW (formerly D. Collen Foundation).Since its incorporation Formac has signed more than 40 feasibility agreements with Tier 1 Pharma companies and SMEs in the field of human and veterinary medicine. To date, Formac is the only company that demonstrated the clinical relevancy of the silica based technology in a clinical setting. | $1.9M |  | Nov 08, 2007 |  |

2 of 2 investments shown.

## Co-investors
- [Allegro Investment Fund](https://shizune.co/investors/profile/allegro-investment-fund) — VC Fund, 1 deal together
- [Fonds Vives II (University of Louvain, UCL)](https://shizune.co/investors/profile/fonds-vives-ii-university-of-louvain-ucl) — VC Fund, 1 deal together
- [Fund+](https://shizune.co/investors/profile/fund) — VC Fund, 1 deal together
- [Gemma Frisius Fund](https://shizune.co/investors/profile/gemma-frisius-fund) — VC Fund, 1 deal together
- [Life Sciences Research Partners V.Z.W.](https://shizune.co/investors/profile/life-sciences-research-partners-v-z-w) — VC Fund, 1 deal together
- [SFPI-FPIM](https://shizune.co/investors/profile/sfpi-fpim) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund
- [OrbiMed](https://shizune.co/investors/profile/orbimed-advisors) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

### Similar country
- [PMV](https://shizune.co/investors/profile/pmv-eu) — VC Fund
- [Limburgse Reconversie Maatschappij](https://shizune.co/investors/profile/limburgse-reconversie-maatschappij) — VC Fund
- [Qbic Fund](https://shizune.co/investors/profile/qbic-fund) — VC Fund

## Featured in investor lists
- [Medical VC Funds in Belgium](https://shizune.co/investors/medical-vc-funds-belgium)
- [Biotechnology VC Funds in Belgium](https://shizune.co/investors/biotechnology-vc-funds-belgium)
- [Biotech VC Funds in Belgium](https://shizune.co/investors/biotech-vc-funds-belgium)

## FAQ

### What does Hunza Ventures invest in?

Hunza Ventures invests primarily in Medical, Health Care and Biotechnology startups, most often at Series A and Funding Round stage. Most of the 2 investments tracked by Shizune back companies in Belgium. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Hunza Ventures last invest?

The most recent investment recorded for Hunza Ventures closed in May 2012. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co